Evidence map›Paper›PMID 36148245›Full record

ArticleFrontiers in immunology2022

TLR2-induced CD8

Anne-Charlotte Antoni, Ekaterina Pylaeva, Bettina Budeus, Jadwiga Jablonska, Ludger Klein-Hitpaß, Marcel Dudda, Stefanie B Flohé

Open access · goldAbstract read
In one paragraph

Article in Frontiers in immunology, 2022. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 9 papers.

0numbers the graph read from it
0cells of the map it votes in
9citing papers in PubMed
0.8field-weighted citation impact, top 31% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

9 citing papers in PubMed, 10 citations in OpenAlex.

  1. Article
  2. Review
  3. Review
  4. Review
  5. Article
  6. Review
  7. Review
  8. Review
  9. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

7 authors at 1 institution in 1 country.

Anne-Charlotte AntoniDepartment of Trauma, Hand, and Reconstructive Surgery, University Hospital Essen, University Duisburg-Essen, Essen, Germany.
Ekaterina PylaevaDepartment of Otorhinolaryngology, University Hospital Essen, University Duisburg-Essen, Essen, Germany.
Bettina BudeusInstitute of Cell Biology, University Hospital Essen, University Duisburg-Essen, Essen, Germany.
Jadwiga JablonskaDepartment of Otorhinolaryngology, University Hospital Essen, University Duisburg-Essen, Essen, Germany.
Ludger Klein-HitpaßInstitute of Cell Biology, University Hospital Essen, University Duisburg-Essen, Essen, Germany.
Marcel DuddaDepartment of Trauma, Hand, and Reconstructive Surgery, University Hospital Essen, University Duisburg-Essen, Essen, Germany.
Stefanie B FlohéDepartment of Trauma, Hand, and Reconstructive Surgery, University Hospital Essen, University Duisburg-Essen, Essen, Germany.
University of Duisburg-Essen · DE

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Sepsis is associated with profound immune dysregulation that increases the risk for life-threatening secondary infections: Dendritic cells (DCs) undergo functional reprogramming due to yet unknown changes during differentiation in the bone marrow (BM). In parallel, lymphopenia and exhaustion of T lymphocytes interfere with antigen-specific adaptive immunity. We hypothesized that there exists a link between T cells and the modulation of DC differentiation in the BM during murine polymicrobial sepsis. Sepsis was induced by cecal ligation and puncture (CLP), a model for human bacterial sepsis. At different time points after CLP, the BM and spleen were analyzed in terms of T-cell subpopulations, activation, and Interferon (IFN)-γ synthesis as well as the number of pre-DCs. BM-derived DCs were generated

Indexed as

LymphopeniaSepsisAnimalsAntigensBone MarrowCD8-Positive T-LymphocytesCell DifferentiationCytokinesDendritic CellsHumansInterferon-gammaInterleukin-12MiceToll-Like Receptor 2AntigensCytokinesInterferon-gammaInterleukin-12TLR2 protein, humanTlr2 protein, mouseToll-Like Receptor 2bone marrowdendritic cellsdifferentiationimmunosuppressionsepsisT cellsTLR - toll-like receptor

Identifiers

PMID36148245
PMCPMC9488929
OpenAlexW4294724941

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.